February 13, 2018 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Stefano Pessina, Steven Collis, Walgreens Boots Alliance, Walgreens Boots Alliance Development, WBA, WBAD
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) is in negotiations to acquire drug distributor AmerisourceBergen Corp., according to published reports. Representatives of WBA executive vice chairman and chief executive officer Stefano Pessina made “a high-level outreach” to representatives of AmerisourceBergen chairman and CEO Steven Collis several weeks ago, The Wall Street Journal reported, citing people familiar
February 3, 2017 by Chain Drug Review
Alliance Boots, slideshow, Walgreens, Walgreens Boots Alliance
Slideshows

Executives from Walgreens Boots Alliance, Walgreens and many of its suppliers were feted at a reception celebrating Chain Drug Review’s publication in December of a special report on the retailer’s recent changes and its positioning for the future. The event was held at the Chicago Marriott Suites in Deerfield, Ill., near the Walgreens headquarters. The
January 4, 2017 by Geoff Walden and Chain Drug Review
Alliance Boots, Chain Drug Review’s Operations Executive of the Year, Richard Ashworth, Walgreens
2017, Featured Articles, Issue 01-02-2017, Issues, Leading Headlines, News, Retail News

DEERFIELD, Ill. — As president of pharmacy and retail operations at Walgreens, Richard Ashworth has helped point the chain in a new direction. The change, both at the company’s support office and in stores, has given the retailer a major boost. Measures ranging from net promoter scores to on-time prescriptions to in-stock levels are up
July 6, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) saw sales and adjusted net earnings rise in its fiscal 2016 third quarter, with adjusted earnings per share exceeding Wall Street’s consensus forecast. WBA said Wednesday that its pending acquisition of Rite Aid Corp. remains on track for completion in the second half of this year, and it
May 5, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Steven Collis, Walgreens, Walgreens Boots Alliance, Walgreens Boots Alliance Development, WBA, WBAD
Business, Featured Articles, Leading Headlines, Supplier News

VALLEY FORGE, Pa. — AmerisourceBergen Corp. has extended its strategic partnership with Walgreens Boots Alliance (WBA) Inc. for another three years. AmerisourceBergen said Thursday that its drug distribution contract with WBA and relationship with Walgreens Boots Alliance Development (WBAD) have been lengthened to 2026. AmerisourceBergen and then-merger partners Walgreen Co. and Alliance Boots had announced
March 31, 2016 by Chain Drug Review
Alliance Boots, Jill Soltau, Jo-Ann Fabric and Craft Stores, Wade Miquelon, Walgreens
Business, Leading Headlines, Retail News

HUDSON, Ohio — Former Walgreen Co. executive vice president and chief financial officer Wade Miquelon has joined Jo-Ann Fabric and Craft Stores, where he will hold the same title. The fabric and craft specialty retailer, which has 850 stores in 49 states, said Miquelon lead the finance organization, real estate, information technology and general counsel.
March 18, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Ornella Barra, Steven Collis, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — As part of a long-term partnership announced three years ago, Walgreens Boots Alliance (WBA) is enlarging its equity stake in AmerisourceBergen. WBA said Friday that it has exercised warrants to buy more than 22,696,912 shares of AmerisourceBergen common stock for about $1.17 billion. The transaction was funded with cash on hand, and
January 27, 2016 by Chain Drug Review
Alliance Boots, James Skinner, Rite Aid, Stefano Pessina, Valeant Pharmaceuticals, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News

NEW YORK — Walgreens Boots Alliance’s deal to acquire Rite Aid and partnership with Valeant Pharmaceuticals will build on WBA’s strong start in its first full year as a unified company, executive vice chairman and CEO Stefano Pessina said here at the annual shareholders meeting. “I am happy to say that we are on track
January 7, 2016 by Chain Drug Review
Alliance Boots, Duane Reade, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) topped Wall Street’s earnings projections for its fiscal 2016 first quarter. WBA said Thursday that for the first quarter ended Nov. 30, 2015, adjusted net earnings attributable to Walgreens Boots Alliance were $1.13 billion, or $1.03 per diluted share, compared with $749 million, or 78 cents per diluted
January 4, 2016 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Uncategorized
DEERFIELD, Ill. — When asked what motivates him, Stefano Pessina, the driving force behind the creation of Walgreens Boots Alliance (WBA), says simply, “I like to build things.” The understated elegance of the response typifies the man, but it underplays the magnitude of his achievement. A savvy dealmaker, Pessina, who has a degree in nuclear
November 9, 2015 by Geoff Walden and Chain Drug Review
Alex Gourlay, Alliance Boots, AmerisourceBergen, Linda Filler, Richard Ashworth, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Business, Issue 11-09-2015, Issues, News

DEERFIELD, Ill. — The acquisition of Rite Aid Corp. culminates sweeping change at Walgreens in the space of a little over three years. In linking its fortunes, starting in June 2012, to Alliance Boots GmbH and its dynamic leader, Stefano Pessina, the chain adopted a global outlook focusing simultaneously on scale and efficiency. Its merger
November 9, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Issue 11-09-2015, Issues, Leading Headlines, Opinion

Stefano Pessina is once again changing the face of community pharmacy. Three years after Alliance Boots, the global retail and distribution powerhouse he created, entered into a partnership with Walgreens, and less than a year after the two companies finalized their merger, Pessina has struck another deal that will reverberate throughout the U.S. health care
August 10, 2015 by Geoff Walden and Chain Drug Review
Alliance Boots, Jim Skinner, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Issue 08-10-2015, Issues, News

DEERFIELD, Ill. — As chief executive officer of Walgreens Boots Alliance Inc. (WBA), Stefano Pessina says he will provide management stability, enabling the company to focus on its operational and strategic tasks. He says the WBA board appointed him CEO (he had been in the role on an interim basis), rather than choose a new
August 10, 2015 by Chain Drug Review
Alliance Boots, beauty advisors, beauty care, ECRM, Joe Tarnowski, LOOK Boutique, Shannon Curtin, Walgreens, Walgreens' Beauty University
2015, Issue 08-10-2015, Issues, News

DEERFIELD, Ill. — Selling into a retail chain as large as Walgreens can be a formidable challenge for even the largest supplier, let alone a fledgling player. To help smooth the path, Shannon Curtin, Walgreens’ group vice president and general merchandise manager for beauty and personal care, recently offered a primer on how to partner